DE69811348D1 - Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen - Google Patents

Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen

Info

Publication number
DE69811348D1
DE69811348D1 DE69811348T DE69811348T DE69811348D1 DE 69811348 D1 DE69811348 D1 DE 69811348D1 DE 69811348 T DE69811348 T DE 69811348T DE 69811348 T DE69811348 T DE 69811348T DE 69811348 D1 DE69811348 D1 DE 69811348D1
Authority
DE
Germany
Prior art keywords
arteries
growth
collateral
mcp
arteriolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811348T
Other languages
English (en)
Other versions
DE69811348T2 (de
Inventor
Wolfgang Schaper
D Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Application granted granted Critical
Publication of DE69811348D1 publication Critical patent/DE69811348D1/de
Publication of DE69811348T2 publication Critical patent/DE69811348T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
DE69811348T 1997-04-04 1998-04-01 Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen Expired - Fee Related DE69811348T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97105647 1997-04-04
PCT/EP1998/001891 WO1998044953A1 (en) 1997-04-04 1998-04-01 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections

Publications (2)

Publication Number Publication Date
DE69811348D1 true DE69811348D1 (de) 2003-03-20
DE69811348T2 DE69811348T2 (de) 2003-12-24

Family

ID=8226664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811348T Expired - Fee Related DE69811348T2 (de) 1997-04-04 1998-04-01 Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen

Country Status (10)

Country Link
US (2) US6592862B1 (de)
EP (2) EP1304123A3 (de)
JP (1) JP2001519795A (de)
AT (1) ATE232399T1 (de)
CA (1) CA2284922A1 (de)
DE (1) DE69811348T2 (de)
DK (1) DK0969877T3 (de)
ES (1) ES2187972T3 (de)
PT (1) PT969877E (de)
WO (1) WO1998044953A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
JP4891477B2 (ja) * 1997-10-02 2012-03-07 マックス−プランク−ゲゼルシャフト ツール フォーデルング デル ヴィッセンシャフテン エー．ヴェー． 血管新生及び／または既存細動脈網から側枝動脈及び／または他の動脈の発達の調節に関する方法
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US6727349B1 (en) 1998-07-23 2004-04-27 Millennium Pharmaceuticals, Inc. Recombinant anti-CCR2 antibodies and methods of use therefor
US6696550B2 (en) 1998-07-23 2004-02-24 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
US6245332B1 (en) 1999-01-15 2001-06-12 The Board Of Trustees Of The Leland Stanford Junior University Modulation of systemic memory T cell trafficking
US6488930B1 (en) 1999-01-15 2002-12-03 Millennium Pharmaceuticals, Inc. Anti-CCR4 antibodies and methods of use therefor
US6329510B1 (en) 1999-01-29 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-CCR1 antibodies and methods of use therefor
WO2000060054A1 (en) * 1999-04-06 2000-10-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
WO2001087314A1 (en) * 2000-05-18 2001-11-22 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis using monocytes
EP1286698A1 (de) * 2000-05-19 2003-03-05 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Verfahren zur verminderung des tumorwachstums und metastatisierung mittels hemmung der mcp-1 aktivität
AU2002253785A1 (en) * 2000-11-08 2003-03-03 Boston Scientific Limited Catheter and implants for the delivery of therapeutic agents to tissues
PT2280070E (pt) * 2001-07-23 2015-10-29 Univ Leland Stanford Junior Métodos e composições para inibição mediada por iarn da expressão génica em mamíferos
US10590418B2 (en) 2001-07-23 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for RNAi mediated inhibition of gene expression in mammals
US20040151721A1 (en) 2001-10-19 2004-08-05 O'keefe Theresa Humanized anti-CCR2 antibodies and methods of use therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
KR970703353A (ko) * 1994-05-16 1997-07-03 로버트 에이치. 벤슨 단핵구 주화성 단백질-4(monocyte chemotactic protein-4)
CA2188575A1 (en) 1995-02-28 1996-09-06 H. Kirk Hammond Gene transfer-mediated angiogenesis therapy
US6544543B1 (en) * 2000-12-27 2003-04-08 Advanced Cardiovascular Systems, Inc. Periodic constriction of vessels to treat ischemic tissue

Also Published As

Publication number Publication date
PT969877E (pt) 2003-06-30
EP0969877B1 (de) 2003-02-12
DE69811348T2 (de) 2003-12-24
JP2001519795A (ja) 2001-10-23
ATE232399T1 (de) 2003-02-15
EP1304123A3 (de) 2003-11-19
CA2284922A1 (en) 1998-10-15
US6592862B1 (en) 2003-07-15
WO1998044953A1 (en) 1998-10-15
US20040023881A1 (en) 2004-02-05
EP0969877A1 (de) 2000-01-12
DK0969877T3 (da) 2003-03-24
ES2187972T3 (es) 2003-06-16
EP1304123A2 (de) 2003-04-23

Similar Documents

Publication Publication Date Title
DE69821011D1 (de) Verfahren zur modulierung der neovaskularisierung und/oder des wachstums von kollateraler arterien und / oder anderer arterien aus bestehenden arteriolären verbindungen
DE69811348T2 (de) Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen
ATE253631T1 (de) Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
DE60235464D1 (de) Knochenmarkersatzmaterial-verbundwerkstoff, verfahren zu seiner herstelllung und kit
DE60222910D1 (de) Vaccinia virus für diagnose und behandlung von tumoren
DE60030323D1 (de) Verfahren und verbindungen zur verlängerung der halbwertzeiten bei der ausscheidung von biowirksamen verbindungen
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
BR0213786A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
FI925986A (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
DE69933998D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
SE8902532L (sv) Bestaemning av plasmaproteiner
ATE407677T1 (de) Gereinigte zubereitungen von 10-propargyl-10- deazaaminopterin und verfahren zu ihrer verwendung in der tumorbehandlung
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
ATE222122T1 (de) Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen
DE69728897D1 (de) Saeugetierchemokine
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
ATE317021T1 (de) Antisense modulierung von lfa-3
ATE435284T1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE320818T1 (de) Mittel zur identifizierung und therapie metastasierender tumore
ATE364180T1 (de) Screeningverfahren mit bnpi und dnpi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee